Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1995 May;39(5):1182-4.
doi: 10.1128/AAC.39.5.1182.

Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients

J J van de Leur  1 , E J Vollaard, A J Janssen, A S Dofferhoff
Affiliations
Clinical Trial

Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients

J J van de Leur et al. Antimicrob Agents Chemother. 1995 May.

Abstract

Pefloxacin (400 mg twice daily) was administered orally for infection prophylaxis in neutropenic patients. Diffusible fecal pefloxacin concentration was determined by bioassay during 24 neutropenic periods. The median diffusible fecal pefloxacin concentration was 187 micrograms/g. This concentration was comparable with those found in volunteers following oral and intravenous administration of pefloxacin (400 mg twice daily) (median of 171 and 155 micrograms/g, respectively). From this study, it is concluded that pefloxacin administered orally results in a predictable high diffusible fecal concentration which leads to effective elimination of susceptible aerobic gram-negative bacilli from the colonic flora.

PubMed Disclaimer

References

    1. J Clin Microbiol. 1985 Jan;21(1):46-76 - PubMed
    1. Antimicrob Agents Chemother. 1994 Mar;38(3):409-14 - PubMed
    1. Rev Infect Dis. 1987 Mar-Apr;9(2):295-328 - PubMed
    1. Clin Invest Med. 1989 Feb;12(1):61-8 - PubMed
    1. Drugs. 1989 May;37(5):628-68 - PubMed

Publication types